{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:03:52Z","timestamp":1793761432445,"version":"4.6.1"},"reference-count":25,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Maternal-to-fetal transfer of the thyroid hormone T4 is essential for prenatal neurodevelopment, but the transporter facilitating trans-placental T4 transport is unknown. Mutations in the thyroid hormone transporter MCT8 cause a neurodevelopmental and metabolic disorder, of which key clinical features can be ameliorated by the T3 analog TRIAC. Should placental MCT8 be physiologically relevant, defective T4 transport across the placenta, which is fetal-derived tissue, could represent a hitherto unrecognized mechanism underlying MCT8 deficiency. We investigated the importance of MCT8 and the trans-placental transport of TRIAC using an ex vivo human placental perfusion setup.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Uncomplicated term placentas were used for the ex vivo dual perfusion experiments to investigate the maternal-to-fetal transfer of T4 or TRIAC in the absence or presence of the MCT8 inhibitor silychristin. Samples were collected at various time points from both maternal and fetal circulations. T4 and rT3 concentrations in the perfused samples were measured using radioimmunoassay and TRIAC using LC\u2013MS\/MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the presence of silychristin, maternal-to-fetal transfer of 100 nM T4 was reduced by \u223c60% (4.2 \u00b1 1.2 nM fetal T4 in MCT8-inhibited placentas versus 10.6 \u00b1 0.6 nM fetal T4 in control placentas). TRIAC was efficiently transferred from the maternal to the fetal circulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study i) shows that MCT8 has a major role in maternal-to-fetal T4 transport, ii) implies that disrupted placental transport of thyroid hormones may contribute to neurodevelopmental delays in MCT8 deficiency and iii) indicates that TRIAC is efficiently transported across the placenta, independent of MCT8, holding potential in prenatal treatment in mothers carrying fetuses with MCT8 deficiency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-26-0003","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:50:14Z","timestamp":1782147014000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":1,"title":["Reduced thyroid hormone transport in a human placental model with inhibited MCT8"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-6015","authenticated-orcid":true,"given":"Zhongli","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Academic Center for Thyroid Diseases 1 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selmar","family":"Leeuwenburgh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Academic Center for Thyroid Diseases 1 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter F","family":"Zijderveld","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry 2 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd A A","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry 2 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunbo","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pharmacology and Vascular Medicine 3 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Broekhuizen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pharmacology and Vascular Medicine 3 , ,","place":["Rotterdam, The Netherlands"]},{"name":"Department of Pediatrics, Division of Neonatology 4 , ,","place":["Rotterdam, The Netherlands"]},{"name":"Department of Cardiology, Division of Experimental Cardiology 5 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavi S","family":"Harhangi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pharmacology and Vascular Medicine 3 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rugina I","family":"Neuman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pharmacology and Vascular Medicine 3 , ,","place":["Rotterdam, The Netherlands"]},{"name":"Department of Obstetrics and Gynecology, Division of Obstetrics and Prenatal Medicine, All Erasmus MC 6 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutchanna M S","family":"Jongejan","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry 2 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda B","family":"de Rijke","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry 2 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin K M","family":"Reiss","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Neonatology 4 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A H Jan","family":"Danser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pharmacology and Vascular Medicine 3 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P","family":"Peeters","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Academic Center for Thyroid Diseases 1 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5392-0519","authenticated-orcid":true,"given":"Marcel E","family":"Meima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Academic Center for Thyroid Diseases 1 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5248-863X","authenticated-orcid":true,"given":"W Edward","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Academic Center for Thyroid Diseases 1 , ,","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2026071509313234500_bib1","doi-asserted-by":"crossref","first-page":"U25","DOI":"10.1530\/eje.0.151u025","article-title":"Role of thyroid hormone during early brain development","volume":"151","author":"Morreale de Escobar","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2026071509313234500_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tem.2011.02.002","article-title":"Delivery of maternal thyroid hormones to the fetus","volume":"22","author":"Patel","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"2026071509313234500_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2265.2009.03743.x","article-title":"Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months","volume":"72","author":"Li","year":"2010","journal-title":"Clin Endocrinol"},{"key":"2026071509313234500_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S2213-8587(19)30153-6","article-title":"Maternal thyroid function during pregnancy and child brain morphology: a time window-specific analysis of a prospective cohort","volume":"7","author":"Jansen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026071509313234500_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1210\/endrev\/bnz008","article-title":"Thyroid hormone transporters","volume":"41","author":"Groeneweg","year":"2020","journal-title":"Endocr Rev"},{"key":"2026071509313234500_bib6","doi-asserted-by":"crossref","first-page":"40128","DOI":"10.1074\/jbc.M300909200","article-title":"Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter","volume":"278","author":"Friesema","year":"2003","journal-title":"J Biol Chem"},{"key":"2026071509313234500_bib7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(04)17226-7","article-title":"Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation","volume":"364","author":"Friesema","year":"2004","journal-title":"Lancet"},{"key":"2026071509313234500_bib8","doi-asserted-by":"crossref","first-page":"E2799","DOI":"10.1210\/jc.2014-2162","article-title":"Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination","volume":"99","author":"Lopez-Espindola","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026071509313234500_bib9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.stem.2017.04.002","article-title":"Modeling psychomotor retardation using iPSCs from MCT8-Deficient patients indicates a prominent role for the blood-brain barrier","volume":"20","author":"Vatine","year":"2017","journal-title":"Cell Stem Cell"},{"key":"2026071509313234500_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1677\/joe.1.06582","article-title":"Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction","volume":"189","author":"Chan","year":"2006","journal-title":"J Endocrinol"},{"key":"2026071509313234500_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.placenta.2010.01.013","article-title":"Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction","volume":"31","author":"Loubiere","year":"2010","journal-title":"Placenta"},{"key":"2026071509313234500_bib12","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/me.2014-1135","article-title":"In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency","volume":"28","author":"Kersseboom","year":"2014","journal-title":"Mol Endocrinol"},{"key":"2026071509313234500_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S2213-8587(19)30155-X","article-title":"Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial","volume":"7","author":"Groeneweg","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026071509313234500_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/thy.2021.0503","article-title":"Thyroid hormone transporters in a human placental cell model","volume":"32","author":"Chen","year":"2022","journal-title":"Thyroid"},{"key":"2026071509313234500_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/thy.2022.0406","article-title":"Asymmetrical transport of thyroxine across human term placenta","volume":"33","author":"Chen","year":"2023","journal-title":"Thyroid"},{"key":"2026071509313234500_bib16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/clinchem\/hvaa022","article-title":"A mass spectrometry-based panel of nine thyroid hormone metabolites in human serum","volume":"66","author":"Jongejan","year":"2020","journal-title":"Clin Chem"},{"key":"2026071509313234500_bib17","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1210\/en.2015-1933","article-title":"Silychristin, a flavonolignan derived from the milk thistle, is a potent inhibitor of the thyroid hormone transporter MCT8","volume":"157","author":"Johannes","year":"2016","journal-title":"Endocrinology"},{"key":"2026071509313234500_bib18","first-page":"2154","article-title":"Type II and type III deiodinase activity in human placenta as a function of gestational age","volume":"81","author":"Koopdonk-Kool","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2026071509313234500_bib19","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1210\/en.2012-1753","article-title":"Expression and function of thyroid hormone transporters in the microvillous plasma membrane of human term placental syncytiotrophoblast","volume":"153","author":"Loubiere","year":"2012","journal-title":"Endocrinology"},{"key":"2026071509313234500_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/thy.2020.0306","article-title":"Prenatal treatment of thyroid hormone cell membrane transport defect caused by MCT8 gene mutation","volume":"31","author":"Refetoff","year":"2021","journal-title":"Thyroid"},{"key":"2026071509313234500_bib21","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1242\/dmm.027227","article-title":"Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafish","volume":"9","author":"Zada","year":"2016","journal-title":"Dis Model Mech"},{"key":"2026071509313234500_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1530\/JOE-16-0323","article-title":"MCT8 deficiency in Purkinje cells disrupts embryonic chicken cerebellar development","volume":"232","author":"Delbaere","year":"2017","journal-title":"J Endocrinol"},{"key":"2026071509313234500_bib23","doi-asserted-by":"crossref","first-page":"15547","DOI":"10.3390\/ijms232415547","article-title":"TRIAC treatment improves impaired brain network function and white matter loss in thyroid hormone transporter Mct8\/Oatp1c1 deficient mice","volume":"23","author":"Reinwald","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026071509313234500_bib24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/thy.2023.0592","article-title":"Identification of human TRIAC transmembrane transporters","volume":"34","author":"Becker","year":"2024","journal-title":"Thyroid"},{"key":"2026071509313234500_bib25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/thy.2023.0467","article-title":"3,3',5-Triiodothyroacetic acid transporters","volume":"34","author":"Chen","year":"2024","journal-title":"Thyroid"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/aop\/ETJ-26-0003\/ETJ-26-0003.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/aop\/ETJ-26-0003\/ETJ-26-0003.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-26-0003\/519736\/etj-26-0003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-26-0003\/519736\/etj-26-0003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:31:43Z","timestamp":1784122303000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/4\/ETJ260003\/77532\/Reduced-thyroid-hormone-transport-in-a-human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-26-0003","relation":{},"ISSN":["2235-0802"],"issn-type":[{"value":"2235-0802","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"ETJ260003"}}